Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
AZN AstraZeneca
- 68.600
- +0.400+0.59%
Close Jan 23 16:00 ET
- 68.550
- -0.050-0.07%
Post 16:58 ET
212.73BMarket Cap33.06P/E (TTM)
68.800High68.150Low3.14MVolume68.750Open68.200Pre Close215.35MTurnover0.10%Turnover Ratio36.01P/E (Static)3.10BShares87.67552wk High5.22P/B211.99BFloat Cap59.19052wk Low1.49Dividend TTM3.09BShs Float87.675Historical High2.16%Div YieldTTM0.95%Amplitude5.373Historical Low68.495Avg Price1Lot Size
About AstraZeneca Company
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Company Profile
SymbolAZN
Company NameAstraZeneca
Listing DateMay 12, 1993
Founded1992
CEOMr. Pascal Soriot
MarketNASDAQ
Employees89900
Securities TypeDR
ADS Ratio1.0 : 0.5
Fiscal Year Ends12-31
AddressCambridge Biomedical Campus,1 Francis Crick Avenue
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB2 0AA
Phone44-20-3749-5000
Websitehttp://www.astrazeneca.co.uk
Company Executives
- Name
- Position
- Salary
- Pascal Soriot
- Executive Director,Chief Executive Officer
- 16.85M
- Dr. Aradhana Sarin
- Executive Director,Chief Financial Officer
- 4.41M
- Michel Demare
- Non-Executive Director,Chairman
- 584.00K
- Rene Haas
- Non-Executive Director
- --
- Diana Layfield
- Non-Executive Director
- 110.00K
- Dr. Euan Ashley
- Non-Executive Director
- 119.00K
- Dr. Andreas Rummelt
- Non-Executive Director
- 110.00K
- Deborah DiSanzo
- Non-Executive Director
- 120.00K
- Anna Olive Magdelene Manz
- Non-Executive Director
- 40.00K
- Sherilyn S. McCoy
- Non-Executive Director
- 175.00K
- Professor Nazneen Rahman
- Non-Executive Director
- 160.00K
- Professor Tony Mok
- Non-Executive Director
- 110.00K
- Marcus Wallenberg
- Non-Executive Director
- 125.00K
- Philip A J Broadley
- Non-Executive Director,Senior Independent Director
- 200.00K
- Adrian C N Kemp
- Company Secretary
- --
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day